A homogeneous fluorometric assay for measuring cell adhesion to immobilized ligand using V-well microtiter plates

Analytical Biochemistry

Volumn 293, Issue 2, 2001, Pages 277-287

  Weetall, Marla ^a   Hugo, Ronald ^a   Friedman, Constance ^a   Maida, Susan ^a   West, Susan ^a   Wattanasin, Sompong ^a   Bouhel, Rochdi ^a   Weitz Schmidt, Gabriele ^a   Lake, Philip ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cell adhesion; High capacity; Homogenous assay; Low molecular weight integrin antagonists; RGD; Selectins; VLA 4

Indexed keywords

CELL ADHESION; CELL MEMBRANES; LIGANDS; MOLECULAR WEIGHT; SHEAR STRESS;

CELL ADHESION MOLECULES; CELL SURFACE RECEPTORS; HIGH CAPACITY; HIGH SIGNAL-TO-NOISE RATIO; INTEGRINS; MEDIATED INTERACTION; SELECTINS; VLA-4;

SIGNAL TO NOISE RATIO;

19 AMINO 16 (SEC BUTYL 20 CARBOXYMETHYL 13 ISOBUTYL 7 ISOPROPYL 6,9,12,15,18 PENTAOXO 1,2 DITHIA 5,8,11,14,17 PENTAAZACYCLOEICOSANE 4 CARBOXYLIC ACID; 2 [2 (2 TERT BUTOXYCARBONYLAMINO 4 METHYLPENTANOYLAMINO) 3 CARBOXYPROPIONYLAMINO] 3 METHYLBUTYRIC ACID METHYL ESTER; 3 (2 TERT BUTOXYCARBONYLAMINO 4 METHYLPENTANOYLAMINO) N ISOBUTYLSUCCINAMIC ACID; 3 [4 METHYL 2 [2 [3 [3 (2 TOLYLUREIDO)]PHENYL]ACETYLAMINO]PENTANOYLAMINO]HEX 5 ENOIC ACID; 5 CARBOXYMETHYL 8 [2 [(9H FLUORENE 1 CARBONYL)AMINO] 4 METHYLPENTANOYLAMINO] 4,7,15 TRIOXO TETRADECAHYDRO 10,11 DITHIA 3ALPHA,6,14 TRIAZACYCLOPENTACYCLOTETRADECENE 13 CARBOXYLIC ACID; BETA1 INTEGRIN; ECHISTATIN; HYBRID PROTEIN; INTEGRIN; LOW MOLECULAR WEIGHT INTEGRIN ANTAGONIST; MONOCLONAL ANTIBODY; N [1 BENZYL 2 (2 CARBAMOYLPYRROLIDIN 1 YL) 2 OXO ETHYL] 3 (4 METHYL 2 PHENYLACETYLAMINOPENTANOYLAMINO)SUCCINAMIC ACID; SELECTIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; DOSE RESPONSE; FLUORESCENCE; FLUOROMETRY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; SIGNAL NOISE RATIO;

EID: 0035876467     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.2001.5140     Document Type: Article

References (35)

1. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration
2. Adhesion molecules as therapeutic targets in the treatment of allergic and immunologically mediated diseases
3. 51Cr-labelled granulocytes
4. Simple colorimetric cell-cell adhesion assay using MTT-stained leukemia cells
5. Nonimmune lymphocyte-macrophage interaction. I. Quantification by an automated colorimetric assay
6. A non-isotopic, highly sensitive, fluorometric cell-cell adhesion microplate assay using calcein AM-labeled lymphocytes
7. Shear stress and the endothelium
8. VLA proteins in the integrin family: Structures, functions, and their role on leukocytes
9. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes
10. 1
11. The minimal essential sequence for a major cell type specific adhesion site (CS-1) with the alternatively-spliced type III connecting segment domain of fibronectin is leucine-aspartic-valine
12. Inhibitors of integrin alpha 4 beta 1 (VLA-4)
13. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment 1 peptide reduces accelerated coronary arteriophathy in rabbit cardiac allografts
14. 1 antagonists as potential anti-inflammatory agents
15. A cyclic hexapeptide is a potent antagonist of α4-integrins
16. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses
17. Very late antigen 4 (VLA-4) antagonists as anti-inflammatory agents
18. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion: Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation
19. The pathophysiologic role of α4 integrin in vivo
20. A direct binding assay for the vascular cell adhesion molecule-1 (VCAM-1) interaction with alpha 4 integrins
21. 1 through chemical cross-linking
22. Selectin-carbohydrate interactions and the initiation of the inflammatory response
23. Small molecule (v) integrin antagonists: Novel anticancer drugs
24. Process to inhibit binding of the integrin alpha 4 beta 1 to VCAM-1 or fibronectin
25. Dual control by divalent cations and mitogenic cytokines of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity expressed by human hematopoietic cells
26. Development of a cell-free binding assay for rat ICAM-1/LFA-1 interactions using a novel anti-rat LFA-1 monoclonal antibody and comparison with a cell based assay
27. The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins
28. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1
29. A visual assay to monitor purification of cell surface antigens reacting with monoclonal antibodies
30. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix
31. Heparan sulfate proteoglycans from mouse mammary epithelial cells
32. Functional mapping of cytotactin: Proteolytic fragments active in cell-substrate adhesion
33. Combinatorial approaches to inhibitors of VLA-4: Piperazine-peptoid-bisarylureas